Jiu 'an Medical: It is recommended that Tianjin adopt the family self-test box. Jiu 'an Medical recommends that everyone use the self-test box once a day for 5 consecutive days in the closed control area for asymptomatic families. Jiu 'an Medical: It is recommended that Tianjin adopt the home self-test box.
Jiu 'an Medical: It is recommended that Tianjin adopt the home self-test box 1. Whether COVID-19 self-test will be implemented in China has always been a social concern. On the evening of 65438+ 10 10, the information disclosed by Jiu 'an Medical on the interactive platform showed that COVID-19 had self-tested fetal movement, and Tianjin was studying the self-test suggestion of Jiu 'an Medical Edition.
Tianjin is studying COVID-19's self-test suggestion.
The news that Tianjin was the first to discover the local Omicron mutant has aroused widespread concern in China.
Gu Qing, Deputy Secretary-General of Tianjin Municipal Government and Director of the Municipal Health and Wellness Committee, introduced the epidemic situation in novel coronavirus, Tianjin on 10/0. Up to now, Tianjin has reported 3 locally confirmed cases1case and asymptomatic infection cases1case. Other newly infected people with positive initial screening will be notified after further verification by the clinical expert group.
Up to 65438+ 10 month 10 hour 15, Tianjin has decided to track 1 152 close contacts and 685 second-level close contacts, all of which have been isolated and controlled. All places related to the epidemic situation should be disinfected at the end. About 75,000 people have been quarantined in this round of epidemic in Tianjin.
● For Omicron mutant virus, Jiuan Medical, a listed company in Tianjin, has detection reagents. On June 5, 2022, the company received the Experimental Report on the Detection Performance of Omicron Mutant Virus by iHealth COVID-19 Antigen Home Self-test OTC Kit. The report showed that OTC kit detected 100% Omicron active virus samples in the experiment, and the maximum CT value was 2 1.59(n=5).
At the same time, in the record form of investor relations activities disclosed in June 5438+ 10/0, regarding whether the company has prepared for the "Deltacuron" strain, Jiu 'an Medical indicated that the company is paying close attention to the mutant strain, and will conduct bioinformatics comparison as soon as possible, start the recombinant N protein test in real time, and conduct performance test after obtaining the mutant strain.
It is worth noting that Securities Times E Company found that in this record of investor relations activities, it also revealed an important message-Jiu 'an Medical has submitted to Tianjin Epidemic Prevention and Control Headquarters the "Proposal on Using Home Self-test Box to Realize Omikong New Crown Epidemic Prevention 1+ 1".
Jiu 'an Medical said that Omicron's mutated virus is highly contagious, and now the number of patients who are positive in Europe and America is on the rise. According to the latest article published in the British Antiviral Experiment, some patients have the ability to detoxify before PCR detection can be positive. In fact, the process of lining up to brush nucleic acid itself is also an exposure. First, the queuing process may last for several hours. Secondly, it is difficult to strictly control the safe distance between people when queuing. Based on this, the company has submitted to the Tianjin Epidemic Prevention and Control Headquarters the Proposal on Using Home Self-test Box to Realize Omicron's Epidemic Prevention 1+ 1.
Household self-test box, also known as COVID-19 self-test (antigen reagent). At present, among the ways of screening infected people in COVID-19, the domestic way is nucleic acid detection, while overseas countries such as Europe and America widely adopt COVID-19 self-test. If Jiu 'an Medical's self-test suggestion can be adopted, it will mean that there will be important changes in the way of screening COVID-19 infected people in China.
At present, China has made great strategic achievements in epidemic prevention and control, which is naturally inseparable from the credit of nucleic acid detection. However, with the change of epidemic prevention situation in COVID-19 and the emergence of self-test advantages, the shortcomings and weak links of prevention and control have been exposed in the cluster epidemic, and many supporters have called for the adjustment of COVID-19 detection methods to reduce the impact of social activities on economic activities.
The record of investor relations activities also revealed that the relevant departments in Tianjin are studying the above-mentioned plan of Jiu 'an Medical. Although it is still unknown whether it can be adopted in the end, the signal released is worthy of attention.
Jiu 'an Medical: It is recommended that Tianjin adopt home self-test kit. 2 There are new trends in COVID-19 test kit for Jiu 'an medical household.
On the evening of 65438+ 10 10, Tianjin Jiu 'an Medical Electronics Co., Ltd. (Jiu 'an Medical, 002432) released the record of investor relations activities interviewed by the media. Regarding the media's suggestion that "as a local enterprise in Tianjin, has Jiu 'an Medical's medicine box been considered for domestic sales?" Or is there any new arrangement on the production line? "Jiu 'an Medical replied that the company has submitted the" Scheme on Using Home Self-test Box to Realize Omicron's Epidemic Prevention 1+ 1 "to the Tianjin Epidemic Prevention and Control Headquarters, and the relevant departments in Tianjin are studying the company's scheme.
Jiu 'an Medical mentioned in the above suggestions that from the epidemic prevention experience of Omicron, Britain and the United States, 1+ 1 > can be achieved by using nucleic acid detection (diagnosis) and home self-test (screening). 2 effect, can more effectively block the spread of Omicron, is an effective public health and epidemic prevention means to control the epidemic situation.
Jiu' an Medical suggested that in the closed control area, for asymptomatic families, everyone should use the self-test box once a day for 5 days, and the measurement results should be reported through the photo App to cooperate with nucleic acid detection; In the control area, for asymptomatic families, each person was measured once a day for 3 consecutive days, and the measurement results were reported through the photo App to cooperate with nucleic acid detection; In the prevention area and other areas, people and families with cold symptoms, people and families with overlapping time and space are encouraged to self-test, and the test results are reported by the photo app.
Jiu 'an Medical also mentioned that it is hoped that Jiu 'an Medical's "iHealth COVID-19 Self-Test Box" can pass the emergency approval of Tianjin Drug Administration and be put into the front line of Tianjin Omicron communication prevention and control as soon as possible.
Jiu' an Medical said that the company will do a good job in epidemic prevention and control of companies and factories in accordance with the relevant requirements of national epidemic prevention and control, and arrange personnel to do a good job in nucleic acid testing. At present, the company's production and operation are normal. The company will continue to pay close attention to the epidemic situation, market conditions and supply chain conditions, and adjust production arrangements in real time.
In the record of investor relations, Jiu 'an Medical responded to the question of "Deltarchon" strain, saying that it is paying close attention to the mutant strain, and will conduct bioinformatics comparison as soon as possible, start the recombinant N protein test in real time, and conduct test performance experiments and other related verifications after obtaining the mutant strain.
Since the end of 20021,Jiu 'an Medical has gained more than 20 daily limit due to the news about COVID-19 antigen test kit, and its share price has fallen recently. 65438+ 10 month 1 1, the share price of Jiu 'an Medical rose. As of press time, the stock price was 54.39 yuan, up nearly 6%, with a market value of 25.7 billion yuan.
Jiu 'an Medical: It is recommended that Tianjin adopt the family self-test box 3. Since the launch of 202111,Jiuan Medical (002432) has risen from 6.38 yuan to 60 yuan, and its share price has nearly tenfold in just over two months. The reason why it is so crazy is that its iHealth COVID-19 antigen home self-test OTC kit is sold in the United States. To add fuel to the fire, Jiu 'an Medical (002432) made a suggestion to Tianjin: adopt home self-test box to realize Omicron epidemic prevention in COVID-19.
Home self-test box, namely COVID-19 self-test (antigen reagent). At present, there are mainly two kinds of tests adopted by countries all over the world. The domestic method is nucleic acid detection, while overseas countries such as Europe and the United States are widely using COVID-19 self-test.
In the United States, home kits are not as accurate as PCR tests conducted in hospitals and testing centers. But their advantage is that they can get results in minutes, not days. Rapid test kits can be bought in many pharmacies without prescription. At present, one in five people in the United States has been diagnosed with COVID-19. With the soaring number of new infections, more and more Americans find that there is no place for nucleic acid testing, and there are often long queues at the doors of those open testing points. In this context, the US government announced on June 4, 65438/KLOC-0 that it would sign a $500 million procurement contract for rapid detection boxes in COVID-19 and distribute them to those in need free of charge upon arrival.
It is reported that overseas demand for test boxes made in China has been increasing. According to customs statistics, the export of diagnostic reagents (mainly COVID-19 antigen reagents) with the HS code of 3002 1500 in China reached 4 1 650,000 yuan, an increase of 80.62 compared with1. Based on the judgment of future industry trends, it is estimated that the total market size of COVID-19 testing in Europe and America is expected to reach 339,654,380+billion US dollars in 2022, equivalent to about 22 billion yuan.
At present, China has made great strategic achievements in epidemic prevention and control, which is naturally inseparable from the credit of nucleic acid detection. However, with the change of epidemic prevention situation in COVID-19 and the emergence of self-test advantages, the shortcomings and weak links of prevention and control have been exposed in the cluster epidemic, and many supporters have called for the adjustment of COVID-19 detection methods to reduce the impact of social activities on economic activities. If the self-test suggestion of Jiu 'an Medical (002432) can be adopted, it will mean that the screening method for infected people in COVID-19 will undergo important changes.
So, apart from Jiu 'an Medical (002432), how many companies in the two cities currently produce household test chambers? According to the author's statistics, there are mainly the following hammer companies that are truly recognized in the interactive platform:
Dean Diagnostics (300244) said on the investor interaction platform that its subsidiary Dean Bio has developed and produced the "Coronavirus Pneumonia-19 antigen detection kit", which can be used for home self-test and has been sold in European countries such as Germany and Austria.
Yahuilong (688575): COVID-19 antigen self-test OTC kit independently developed by the company has obtained EU CE certification and can be sold in EU countries and countries that recognize EU CE certification. At present, the company is actively developing international market-related business.
Botuo Bio (688767) said on the investor interaction platform that the COVID-19 antigen self-test reagent produced by the company has obtained CE certificate and can be exported to the EU.
MasterCard Bio (688399): The company's COVID-19 antigen rapid detection kit (self-test) obtained the EU CE certificate.
Foucault Medical (30 1087) said in the "interactive platform" of Shenzhen Stock Exchange that the application procedure of the company's home self-test COVID-19 testing product qualification is in progress, and the company will actively cooperate with various evaluation work and strive for the product to be listed as soon as possible.
Lepu Medical (300003): The company's COVID-19 antigen self-test kit obtained EU CE certification, European DOC and German home test registration certificate.
Cape Bio (300639): It means that the company has established the COVID-19 nucleic acid rapid detection kit. Please pay attention to the company's announcement on the progress of this matter.
Novel coronavirus antigen self-detection reagent of Wanfu Bio (300482) Company can be operated by individuals collecting nasal swab samples by themselves, and the results can be obtained quickly in 15 minutes, which is convenient for individuals and families to quickly detect COVID-19, and can better meet the needs of family detection and epidemic prevention and control in various countries, further enriching Wanfu Bio's full-scene COVID-19 detection solution.
Oriental Biotech (688298): It is reported that COVID-19's home inspection has been carried out in Britain, and the reagents of Oriental Biotech have been shipped and exported.
Novel coronavirus antigen test kit of Hot scene Bio(688068) was certified by the German Federal Institute for Drugs and Medical Devices (BfArM) earlier, which can be used for free testing at home and can be sold in supermarkets, pharmacies and Internet stores in Germany.